Lawmakers ask FDA for timeline on reclassifying hydrocodone

02/17/2013 | Hill, The

The FDA should increase restrictions on painkillers, a bipartisan group of senators and representatives says in a letter to the agency. The lawmakers want to see a time frame for the reclassification of hydrocodone drugs from Schedule III to Schedule II. "The American people have waited too long for action from this agency," the lawmakers wrote.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ